BAY 94-9343
BAY 94-9343 Uses, Dosage, Side Effects, Food Interaction and all others data.
BAY 94-9343 is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer).
| Trade Name | BAY 94-9343 |
| Generic | Anetumab ravtansine |
| Anetumab ravtansine Other Names | Anetumab ravtansine, BAY 94-9343 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here BAY 94-9343
